Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Anti-aging biotech NewLimit nabs $435M to rejuvenate old cells
Backed by Peter Thiel's Founders Fund, NewLimit looks to push a liver-targeting mRNA therapeutic into the clinic next year.
Darren Incorvaia
Jun 2, 2026 1:00pm
Fierce Biotech Fundraising Tracker '26: Ona, Contraline & more
Jun 2, 2026 10:00am
Apogee bags $1.3B royalty funding deal to advance eczema hopeful
May 27, 2026 8:57am
With $30M, Oorja Bio breathes new life into fibrosis candidate
May 20, 2026 10:31am
Create Medicines fashions $122M raise for in vivo CAR-T dreams
May 14, 2026 9:42am
Amgen-backed quantum computing firm plans IPO
May 10, 2026 8:25am
